XML 39 R28.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Restructuring charges and impairment charges (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2018
Restructuring and Related Activities [Abstract] |
Restructuring and Other Impairment Charges | Restructuring charges (credits) by reportable operating segment, and by all other operating segments in the aggregate, for the three and nine months ended September 30, 2018 and October 1, 2017 are set forth in the following table:
| Three Months Ended |  | Nine Months Ended
| September 30, 2018 |  | October 1, 2017 |  | September 30, 2018 |  | October 1, 2017
| (Dollars in thousands)
Vascular North America | $ | 203 |  |  | $ | 582 |  |  | $ | 725 |  |  | $ | 1,663 |
Interventional North America | (26 | ) |  | (228 | ) |  | 881 |  |  | 4,178 |
Anesthesia North America | 38 |  |  | 220 |  |  | 164 |  |  | 1,031 |
EMEA | 1,520 |  |  | (632 | ) |  | 54,310 |  |  | 6,483 |
All other | 229 |  |  | (34 | ) |  | 2,435 |  |  | 368 |
Restructuring charges | $ | 1,964 |  |  | $ | (92 | ) |  | $ | 58,515 |  |  | $ | 13,723 |
The following tables provide information regarding restructuring and impairment charges (credits) recognized by the Company for the three and nine months ended September 30, 2018 and October 1, 2017:
Three Months Ended September 30, 2018 |  |  |  |  |
| Termination benefits |  | Other costs (1) |  | Total
| (Dollars in thousands)
2018 Footprint realignment plan | $ | 1,119 |  |  | $ | 145 |  |  | $ | 1,264 |
Other restructuring programs (2) | 468 |  |  | 232 |  |  | 700 |
Restructuring charges | $ | 1,587 |  |  | $ | 377 |  |  | $ | 1,964 |
Asset impairment charges | — |  |  | 17,245 |  |  | 17,245 |
Restructuring and impairment charges | $ | 1,587 |  |  | $ | 17,622 |  |  | $ | 19,209 |
Three Months Ended October 1, 2017 |  |  |  |  |
| Termination benefits |  | Other costs (1) |  | Total
| (Dollars in thousands)
Restructuring (credits) charges (3) | $ | (554 | ) |  | $ | 462 |  |  | $ | (92 | )
Nine Months Ended September 30, 2018 |  |  |  |  |
| Termination benefits |  | Other costs (1) |  | Total
| (Dollars in thousands)
2018 Footprint realignment plan | $ | 53,463 |  |  | $ | 275 |  |  | $ | 53,738 |
2016 Footprint realignment plan | 2,379 |  |  | 417 |  |  | 2,796 |
Other restructuring programs (4) | 1,318 |  |  | 663 |  |  | 1,981 |
Restructuring charges | $ | 57,160 |  |  | $ | 1,355 |  |  | $ | 58,515 |
Asset impairment charges | — |  |  | 19,110 |  |  | 19,110 |
Restructuring and impairment charges | $ | 57,160 |  |  | $ | 20,465 |  |  | $ | 77,625 |
Nine Months Ended October 1, 2017 |  |  |  |  |
| Termination benefits |  | Other costs (1) |  | Total
| (Dollars in thousands)
2017 Vascular Solutions integration program | $ | 4,534 |  |  | $ | 92 |  |  | $ | 4,626 |
2017 EMEA restructuring program | 5,822 |  |  | 84 |  |  | 5,906 |
2016 Footprint realignment plan | 1,099 |  |  | 233 |  |  | 1,332 |
Other restructuring programs (5) | 1,352 |  |  | 507 |  |  | 1,859 |
Restructuring charges | $ | 12,807 |  |  | $ | 916 |  |  | $ | 13,723 |
(1) | Other costs include facility closure, contract termination, and other exit costs.
(2) Other restructuring programs include the 2016 and 2014 Footprint realignment plans, the 2017 Vascular Solutions integration program, the 2017 EMEA restructuring program and the other 2016 restructuring programs.
(3) | Restructuring charges (credits) include activity related to the 2017 Vascular Solutions integration program, the 2017 EMEA restructuring program, the 2016 and 2014 footprint realignment plans, the 2017 Pyng integration program and the other 2016 restructuring programs. The Company committed to the 2017 Pyng integration program, which relates to the integration of Pyng Medical Corp. (“Pyng”) into the Company, during the second quarter of 2017, following the Company’s acquisition of Pyng in April 2017.
(4) Other restructuring programs include the 2014 Footprint realignment plan, the 2017 Vascular Solutions integration program, the 2017 EMEA restructuring program and the other 2016 restructuring programs. (5) Other restructuring programs include the 2014 Footprint realignment plan, the 2017 Pyng integration program and the other 2016 restructuring programs.
Summary Of Current Cost Estimates By Major Type Of Cost Table | The following table provides a summary of the Company’s cost estimates by major type of expense associated with the 2018 Footprint realignment plan:
Type of expense | Total estimated amount expected to be incurred
Termination benefits | $60 million to $70 million
Other exit costs (1) | $2 million to $4 million
Restructuring charges | $62 million to $74 million
Restructuring related charges (2) | $40 million to $59 million
Total restructuring and restructuring related charges | $102 million to $133 million
(1) | Includes contract termination, facility closure, employee relocation, equipment relocation and outplacement costs.
(2) | Consists of pre-tax charges related to accelerated depreciation and other costs directly related to the plan, primarily project management costs and costs to transfer manufacturing operations to the new locations, as well as a charge associated with the Company’s exit from the facilities that is expected to be imposed by the taxing authority in the affected jurisdiction. Excluding this tax charge, substantially all of the charges are expected to be recognized within costs of goods sold.

X
- Definition Summary of current cost estimates by major type of cost. + References No definition available. + Details
Name: | tfx_SummaryOfCurrentCostEstimatesByMajorTypeOfCostTableTableTextBlock
Namespace Prefix: | tfx_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 5.P.3) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 + Details
Name: | us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration